Skip to Main content Skip to Navigation
Theses

Contrôle de la signalisation oncogénique du mutant L858R de l'EGFR par la protéine suppresseur de tumeur p14ARF dans les adénocarcinomes pulmonaires

Abstract : Control of EGFR-L858R oncogenic signaling pathway by the p14ARF tumor suppressor in lung adenocarcinoma. The EGF receptor (EGFR) is a strong oncogene involved in lung carcinogenesis. In these cancers, sensitivity to inhibitors of the EGFR tyrosine kinase activity (EGFR-TKI) has been shown to be related to the presence of activating mutations in the TK domain of EGFR (mainly L858R and Del19). However, the association between mutations and responsiveness to EGFR-TKI based treatment is more complex than previously envisioned, underlying the pressing need to study thoroughly the molecular mechanisms of lung cancer growth. We previously showed that almost all lung cancer with EGFR activated mutations has very low or undetectable levels of the p14ARF tumor suppressor protein. These results led us to postulate that expression of p14ARF is an efficient break against clonal proliferation of these cells. We report for the first time a relationship between p14ARF and mutant EGFR-L858R in which p14ARF inhibits the growth of EGFR-L858R expressing cells by inducing apoptosis. The p14ARF tumor suppressor effects involve an original STAT3 pro-apoptotic function that drives the inhibition of the anti-apoptotic Bcl-2 protein. Moreover, we show that the EGFR-L858R mutant maintains their survival and proliferation characteristics by inhibiting p14ARF expression and consequently the STAT3/Bcl-2 pro-apoptotic pathway. Our results also identify p14ARF as a new transcriptional target of STAT3, therefore providing evidence of a positive feed-back loop that could maintain STAT3 pro-apoptotic pathway. Based on these data, we suggest that manipulation of this pathway could be a therapeutic strategy for lung cancer treatment.
Document type :
Theses
Complete list of metadata

https://tel.archives-ouvertes.fr/tel-00767340
Contributor : Abes Star :  Contact
Submitted on : Wednesday, December 19, 2012 - 4:47:11 PM
Last modification on : Friday, October 23, 2020 - 5:04:15 PM
Long-term archiving on: : Wednesday, March 20, 2013 - 11:32:56 AM

File

20736_OZENNE_2011_archivage.pd...
Version validated by the jury (STAR)

Identifiers

  • HAL Id : tel-00767340, version 1

Collections

Citation

Peggy Ozenne. Contrôle de la signalisation oncogénique du mutant L858R de l'EGFR par la protéine suppresseur de tumeur p14ARF dans les adénocarcinomes pulmonaires. Sciences agricoles. Université de Grenoble, 2011. Français. ⟨NNT : 2011GRENV084⟩. ⟨tel-00767340⟩

Share

Metrics

Record views

1336

Files downloads

1414